No-cost manual method for preparation of tissue microarrays having high quality comparable to semiautomated methods

Applied Immunohistochemistry and Molecular Morphology

Volumn 21, Issue 3, 2013, Pages 271-274

  Foda, Abd Al Rahman Mohammad ^a  

^a MANSOURA UNIVERSITY   (Egypt)

Author keywords

cheap; colorectalcarcinoma; manual; pencil tips; tissue microarray

Indexed keywords

EOSIN; EPIDERMAL GROWTH FACTOR RECEPTOR; HEMATOXYLIN; PARAFFIN; UVOMORULIN;

ANTIGEN RETRIEVAL; ARTICLE; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; COST; HUMAN; IMMUNODETECTION; IMMUNOHISTOCHEMISTRY; MICROTOME; PRIORITY JOURNAL; THICKNESS; TISSUE MICROARRAY;

ADENOCARCINOMA; AUTOMATION, LABORATORY; CADHERINS; COLONIC NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; PARAFFIN EMBEDDING; RECEPTOR, EPIDERMAL GROWTH FACTOR; TISSUE ARRAY ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84876994628     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e318268a93f     Document Type: Article

References (25)

1. Kononen J, Bubendorf L, Kallioniemi A, et al. Tissue microarrays for high-throughput molecular profiling of tumor specimens. Nat Med. 1998;4:844-847.
2. Parsons M, Grabsch H. How to make tissue microarrays? Diagn Histopathol. 2009;15:142-150.
3. Shebl AM, Zalata KR, Amin MM, et al. An inexpensive method of small paraffin tissue microarrays using mechanical pencil tips. Diagn Pathol. 2011;6:117-121.
4. Gillett CE, Springall RJ, Barnes DM, et al. Multiple tissue core arrays in histopathology research: a validation study. J Pathol. 2000;192:549-553.
5. Hidalgo A, Piña P, Guerrero G, et al. A simple method for the construction of small format tissue arrays. J Clin Pathol. 2003; 56:144-146.
6. Pan CC, Chen PC, Chiang H. An easy method for manual construction of high-density tissue arrays. Appl Immunohistochem Mol Morphol. 2004;12:370-372.
7. Pires AR, Andreiuolo Fda M, de Souza SR. TMA for all: a new method for the construction of tissue microarrays without recipient paraffin block using custom-built needles. Diagn Pathol. 2006;1:14-18.
8. Vogel UF, Bueltmann BD. Simple, inexpensive, and precise paraffin tissue microarrays constructed with a conventional microcompound table and a drill grinder. Am J Clin Pathol. 2006;126:342-348.
9. Vogel UF. Simple, inexpensive and precise paraffin tissue microarrays constructed with predrilled ordinary steel embedding moulds. Histopathology. 2008;52:255-256.
10. Fernebro E, Dictor M, Bendahl PO, et al. Evaluation of the tissue microarray technique for immunohistochemical analysis in rectal cancer. Arch Pathol Lab Med. 2002;126:702-705.
11. Jourdan F, Sebbagh N, Comperat E, Mourra N, et al. Tissue microarray technology: validation in colorectal carcinoma and analysis of p53, hMLH1, and hMSH2 immunohistochemical expression. Virchows Arch. 2003;443:115-121.
12. Al-Kuraya KS, Bavi PP, Ezzat AA, et al. Colorectal carcinoma from Saudi Arabia. Analysis of MLH-1, MSH-2 and p53 genes by immunohistochemistry and tissue microarray analysis. Saudi Med J. 2006;27:323-328.
13. Buhmeida A, Bendardaf R, Hilska M, et al. Prognostic significance of matrix metalloproteinase-9 (MMP-9) in stage II colorectal carcinoma. J Gastrointest Cancer. 2009;40:91-97.
14. Harbaum L, PollheimerMJ, Bauernhofer T, et al. Clinicopathological significance of prolactin receptor expression in colorectal carcinoma and corresponding metastases. Mod Pathol. 2010;23:961-971.
15. Yao HB, Wu AG, Huang ZH. Expression of survivin and its clinical significance in colorectal carcinoma. Di Yi Jun Yi Da Xue Xue Bao. 2004;24:1412-1415.
16. Yao HB, Wu AG, Chen YJ, et al. Expression of COX-2 protein in colorectal carcinoma and the clinical implication. Di Yi Jun Yi Da Xue Xue Bao. 2005;25:1524-1528.
17. Zeng X, Wang P, Wu SF, et al. Protein overexpression and gene copy number of EGFR and HER2 in colorectal carcinoma. Zhonghua Bing Li Xue Za Zhi. 2007;36:447-452.
18. Buhmeida A, Bendardaf R, Hilska M, et al. PLA2 (group IIA phospholipase A2) as a prognostic determinant in stage II colorectal carcinoma. Ann Oncol. 2009;20:1230-1235.
19. Li ZX, Zeng SD, Liu YD, et al. Clinicopathological significance of expression and amplification of P21-activated kinase 1 gene in colorectal carcinoma. Zhonghua Wei Chang Wai Ke Za Zhi. 2009;12:185-188.
20. Xu B, Thong N, Tan D, et al. Expression of thyroid transcription factor-1 in colorectal carcinoma. Appl Immunohistochem Mol Morphol. 2010;18:244-249.
21. Oliveira LA, Artigiani-Neto R, Waisberg DR, et al. NM23 protein expression in colorectal carcinoma using TMA (tissue microarray): association with metastases and survival. Arq Gastroenterol. 2010;47:361-367.
22. Zheng HC, Sugawara A, Okamoto H, et al. Expression profile of the REG gene family in colorectal carcinoma. J Histochem Cytochem. 2011;59:106-115.
23. Pacifico MD, Grover R, Richman PI, et al. CD44v3 levels in primary cutaneous melanoma are predictive of prognosis: assessment by the use of tissuemicroarray. Int J Cancer. 2006;118:1460-1464.
24. Arafa M, Boniver J, Delvenne P. Progression model tissue microarray (TMA) for the study of uterine carcinomas. Dis Markers. 2010;28:267-272.
25. Chen WC, Lin MS, Zhang BF, et al. Survey of molecular profiling during human colon cancer development and progression by immunohistochemical staining on tissue microarray. World J Gastroenterol. 2007;13:699-708.